The DOI matches its Crossref record; 115 of the 115 references it cites were found in a registry or an index.
Ecstasy (MDMA): a review of its possible persistent psychological effects
Open accessAbstract
Rationale: Recreational use of "ecstasy" (3,4-methylenedioxymethamphetamine; MDMA) has become increasingly widespread. Until recently, however, little was known about the possible persistent psychological effects of extensive use of this drug. Objective: The aim of the present review is to evaluate recent empirical evidence concerning the persistent psychological sequelae of recreational ecstasy use. Methods: The methodologies of open trial studies of recreational ecstasy users are evaluated and reports of the presence or absence of persistent psychological problems are related to the extent of past exposure to ecstasy. Results: There is growing evidence that chronic, heavy, recreational use of ecstasy is associated with sleep disorders, depressed mood, persistent elevation of anxiety, impulsiveness and hostility, and selective impairment of episodic memory, working memory and attention. There is tentative evidence that these cognitive deficits persist for at least 6 months after abstinence, whereas anxiety and hostility remit after a year of abstinence. The possibility that some of these psychological problems are caused by ecstasy-induced neurotoxicity is supported by preclinical evidence of MDMA-induced neurotoxicity and behavioural deficits, evidence of depleted serotonin in heavy ecstasy users, and by dose-response relationships between the extent of exposure to ecstasy and the severity of cognitive impairments. Conclusions: An increasing number of young, heavy ecstasy users are at significant risk of persistent cognitive impairments and disturbances of affect and personality. Some of these problems may remit after abstinence, but residual neurotoxicity and decline of serotonergic function with age may result in recurrent psychopathology and premature cognitive decline.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Specific impairments of planning
Shallice, T. (1982) · Philosophical Transactions of the Royal Society of London. B, Biological Sciences · doi:10.1098/rstb.1982.0082 · Cited by 3,741
A Systematic Method for Clinical Description and Classification of Personality Variants: A Proposal
Cloninger, C. R. (1987) · Archives of General Psychiatry · doi:10.1001/archpsyc.1987.01800180093014 · Cited by 3,678
A Standardized Memory Scale for Clinical Use
Wechsler, D. (1945) · The Journal of Psychology · doi:10.1080/00223980.1945.9917223 · Cited by 2,919
An inventory for assessing different kinds of hostility.
Buss, A. H., & Durkee, A. (1957) · Journal of Consulting Psychology · doi:10.1037/h0046900 · Cited by 2,575
A Modified Card Sorting Test Sensitive to Frontal Lobe Defects
Nelson, H. E. (1976) · Cortex · doi:10.1016/s0010-9452(76)80035-4 · Cited by 2,454
Frontal-subcortical circuits and human behavior
Cummings, J. L. (1993) · Archives of Neurology · doi:10.1001/archneur.1993.00540080076020 · Cited by 2,262
(2012) · SpringerReference · doi:10.1007/springerreference_179754 · Cited by 2,089
Sensation seeking in England and America: cross-cultural, age, and sex comparisons
Zuckerman, M., Eysenck, S. B., & Eysenck, H. J. (1978) · Journal of Consulting and Clinical Psychology · doi:10.1037/0022-006x.46.1.139 · Cited by 1,905
DOPAMINE (3-HYDROXYTYRAMINE) AND BRAIN FUNCTION
HORNYKIEWICZ, O. (1966) · Pharmacological Reviews · doi:10.1016/s0031-6997(25)07154-6 · Cited by 1,442
MISHKIN, M. (1978) · Nature · doi:10.1038/273297a0 · Cited by 1,196
Delgado, P. L. (1990) · Archives of General Psychiatry · doi:10.1001/archpsyc.1990.01810170011002 · Cited by 924
Tryptophan depletion causes a rapid lowering of mood in normal males
Young, S. N., Smith, S. E., Pihl, R. O., & Ervin, F. R. (1985) · Psychopharmacology · doi:10.1007/bf00431803 · Cited by 713
McCann, U., Szabo, Z., Scheffel, U., Dannals, R., & Ricaurte, G. (1998) · The Lancet · doi:10.1016/s0140-6736(98)04329-3 · Cited by 660
O'Hearn, E., Battaglia, G., De Souza, E., Kuhar, M., & Molliver, M. (1988) · The Journal of Neuroscience · doi:10.1523/jneurosci.08-08-02788.1988 · Cited by 542
Neurotoxicity of the psychedelic amphetamine, methylenedioxymethamphetamine.
Schmidt, C. J. (1987) · The Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(25)22673-8 · Cited by 529
Hegerl, U., & Juckel, G. (1993) · Biological Psychiatry · doi:10.1016/0006-3223(93)90137-3 · Cited by 472
Battaglia, G., Yeh, S. Y., O'Hearn, E., Molliver, M. E., Kuhar, M. J., & De Souza, E. B. (1987) · The Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(25)39191-3 · Cited by 458
Commins, D. L., Vosmer, G., Virus, R. M., Woolverton, W. L., Schuster, C. R., & Seiden, L. S. (1987) · The Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-5347(25)00317-9 · Cited by 453
Central Serotonin and Impulsive Aggression
Coccaro, E. F. (1989) · British Journal of Psychiatry · doi:10.1192/s0007125000291769 · Cited by 451
Vollenweider, F. X., Gamma, A., Liechti, M., & Huber, T. (1998) · Neuropsychopharmacology · doi:10.1016/s0893-133x(98)00013-x · Cited by 448
The Hamilton Depression Scale: EVALUATION OF OBJECTIVITY USING LOGISTIC MODELS
Bech, P., Allerup, P., Gram, L. F., Reisby, N., Rosenberg, R., Jacobsen, O., & Nagy, A. (1981) · Acta Psychiatrica Scandinavica · doi:10.1111/j.1600-0447.1981.tb00676.x · Cited by 425
Green, A. R., Cross, A. J., & Goodwin, G. M. (1995) · Psychopharmacology · doi:10.1007/bf02246288 · Cited by 415
Subjective Reports of the Effects of MDMA in a Clinical Setting
Greer, G., & Tolbert, R. (1986) · Journal of Psychoactive Drugs · doi:10.1080/02791072.1986.10472364 · Cited by 413
Recreational MDMA use in Sydney: a profile of ‘Ecstasy’ users and their experiences with the drug
SOLOWIJ, N., HALL, W., & LEE, N. (1992) · British Journal of Addiction · doi:10.1111/j.1360-0443.1992.tb02003.x · Cited by 413
Spoont, M. R. (1992) · Psychological Bulletin · doi:10.1037//0033-2909.112.2.330 · Cited by 408
Memory impairment in abstinent MDMA ("Ecstasy") users
Bolla, K. I., McCann, U. D., & Ricaurte, G. A. (1998) · Neurology · doi:10.1212/wnl.51.6.1532 · Cited by 373
Ecstasy use in Australia: patterns of use and associated harm
Topp, L., Hando, J., Dillon, P., Roche, A., & Solowij, N. (1999) · Drug and Alcohol Dependence · doi:10.1016/s0376-8716(99)00002-2 · Cited by 352
Ecstasy (MDMA) effects upon mood and cognition: before, during and after a Saturday night dance
Parrott, A. C., & Lasky, J. (1998) · Psychopharmacology · doi:10.1007/s002130050714 · Cited by 340
Hatzidimitriou, G., McCann, U. D., & Ricaurte, G. A. (1999) · The Journal of Neuroscience · doi:10.1523/jneurosci.19-12-05096.1999 · Cited by 339
McCann, U. D., Ridenour, A., Shaham, Y., & Ricaurte, G. A. (1994) · Neuropsychopharmacology · doi:10.1038/npp.1994.15 · Cited by 332
(1988) · PubMed · Cited by 313
MDMA-induced neurotoxicity: Parameters of degeneration and recovery of brain serotonin neurons
Battaglia, G., Yeh, S. Y., & De Souza, E. B. (1988) · Pharmacology Biochemistry and Behavior · doi:10.1016/0091-3057(88)90155-4 · Cited by 312
Tryptophan depletion in normal volunteers produces selective impairments in learning and memory
Park, S. B., Coull, J. T., McShane, R. H., Young, A. H., Sahakian, B. J., Robbins, T. W., & Cowen, P. J. (1994) · Neuropharmacology · doi:10.1016/0028-3908(94)90089-2 · Cited by 310
Impaired cognitive performance in drug free users of recreational ecstasy (MDMA)
Gouzoulis-Mayfrank, E. (2000) · Journal of Neurology, Neurosurgery & Psychiatry · doi:10.1136/jnnp.68.6.719 · Cited by 305
McCann, U. D., Mertl, M., Eligulashvili, V., & Ricaurte, G. A. (1999) · Psychopharmacology · doi:10.1007/s002130050967 · Cited by 300
Schiff, A. A. (1978) · British Journal of Psychiatry · doi:10.1192/s0007125000003640 · Cited by 299
Sarter, M., & Markowitsch, H. J. (1985) · Behavioral Neuroscience · doi:10.1037//0735-7044.99.2.342 · Cited by 294
(±)3,4-Methylenedioxymethamphetamine (‘Ecstasy’)-Induced Serotonin Neurotoxicity: Studies in Animals
Ricaurte, G. A., Yuan, J., & McCann, U. D. (2000) · Neuropsychobiology · doi:10.1159/000026664 · Cited by 292
STEELE, T. D., McCANN, U. D., & RICAURTE, G. A. (1994) · Addiction · doi:10.1111/j.1360-0443.1994.tb03330.x · Cited by 289
Recreational Use of “Ecstasy” (MDMA) Is Associated with Elevated Impulsivity
Morgan, M. J. (1998) · Neuropsychopharmacology · doi:10.1016/s0893-133x(98)00012-8 · Cited by 288
Self-citationSerotonin, memory, and the aging brain
McEntee, W. J., & Crook, T. H. (1991) · Psychopharmacology · doi:10.1007/bf02244194 · Cited by 284
CURRAN, H. V., & TRAVILL, R. A. (1997) · Addiction · doi:10.1111/j.1360-0443.1997.tb02951.x · Cited by 282
Memory deficits associated with recreational use of "ecstasy" (MDMA)
Morgan, M. J. (1999) · Psychopharmacology · doi:10.1007/s002130050803 · Cited by 281
Self-citationSemple, D. M., Ebmeier, K. P., Glabus, M. F., O'Carroll, R. E., & Johnstone, E. C. (1999) · British Journal of Psychiatry · doi:10.1192/bjp.175.1.63 · Cited by 280
Psychobiological problems in heavy ‘ecstasy’ (MDMA) polydrug users
Parrott, A. C., Sisk, E., & Turner, J. J. D. (2000) · Drug and Alcohol Dependence · doi:10.1016/s0376-8716(00)80013-7 · Cited by 279
Fischer, C., Hatzidimitriou, G., Wlos, J., Katz, J., & Ricaurte, G. (1995) · The Journal of Neuroscience · doi:10.1523/jneurosci.15-08-05476.1995 · Cited by 268
Ricaurte, G. A., Martello, A. L., Katz, J. L., & Martello, M. B. (1992) · The Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(25)11083-5 · Cited by 268
Subjective Memory Assessment and Test Performance in Elderly Adults
Sunderland, A., Watts, K., Baddeley, A. D., & Harris, J. E. (1986) · Journal of Gerontology · doi:10.1093/geronj/41.3.376 · Cited by 250
Liechti, M. (2000) · Neuropsychopharmacology · doi:10.1016/s0893-133x(99)00148-7 · Cited by 248
Ricaurte, G. A., DeLanney, L. E., Irwin, I., & Langston, J. W. (1988) · Brain Research · doi:10.1016/0006-8993(88)91309-1 · Cited by 245
O'Shea, E., Granados, R., Esteban, B., Colado, M. I., & Green, A. R. (1998) · Neuropharmacology · doi:10.1016/s0028-3908(98)00029-x · Cited by 242
Cognitive performance and serotonergic function in users of ecstasy
Verkes, R. J., Gijsman, H. J., Pieters, M. S. M., Schoemaker, R. C., de Visser, S., Kuijpers, M., Pennings, E. J. M., de Bruin, D., Van de Wijngaart, G., Van Gerven, J. M. A., et al. (2001) · Psychopharmacology · doi:10.1007/s002130000563 · Cited by 233
The Psychological and Physiological Effects of MDMA on Normal Volunteers
Downing, J. (1986) · Journal of Psychoactive Drugs · doi:10.1080/02791072.1986.10472366 · Cited by 226
Cognitive performance in recreational users of MDMA or 'ecstasy': evidence for memory deficits
Parrott, A. C., Lees, A., Garnham, N. J., Jones, M., & Wesnes, K. (1998) · Journal of Psychopharmacology · doi:10.1177/026988119801200110 · Cited by 223
The acute effects of methylenedioxymethamphetamine on dopamine release in the awake-behaving rat
Yamamoto, B. K., & Spanos, L. J. (1988) · European Journal of Pharmacology · doi:10.1016/0014-2999(88)90564-x · Cited by 217
Development of a more reliable version of the Matching Familiar Figures Test.
Cairns, E., & Cammock, T. (1978) · Developmental Psychology · doi:10.1037//0012-1649.14.5.555 · Cited by 216
MDMA (`ecstasy') consumption in the context of polydrug abuse: a report on 150 patients
Schifano, F., Di Furia, L., Forza, G., Minicuci, N., & Bricolo, R. (1998) · Drug and Alcohol Dependence · doi:10.1016/s0376-8716(98)00051-9 · Cited by 216
Reneman, L., Booij, J., Schmand, B., van den Brink, W., & Gunning, B. (2000) · Psychopharmacology · doi:10.1007/s002130050057 · Cited by 210
(1987) · New England Journal of Medicine · doi:10.1056/nejm198712103172419 · Cited by 195
Diversity of Psychopathology Associated with use of 3,4-Methylenedioxymethamphetamine (‘Ecstasy’)
Mcguire, P. K., Cope, H., & Fahy, T. A. (1994) · British Journal of Psychiatry · doi:10.1192/bjp.165.3.391 · Cited by 187
Working memory deficits in current and previous users of MDMA (‘ecstasy’)
Wareing, M., Fisk, J. E., & Murphy, P. N. (2000) · British Journal of Psychology · doi:10.1348/000712600161772 · Cited by 186
Neurochemistry and Neurotoxicity of 3,4‐Methylenedioxymethamphetamine (MDMA, “Ecstasy”)
McKenna, D. J., & Peroutka, S. J. (1990) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.1990.tb13277.x · Cited by 183
Nichols, D. E., Lloyd, D. H., Hoffman, A. J., Nichols, M. B., & Yim, G. (1982) · Journal of Medicinal Chemistry · doi:10.1021/jm00347a010 · Cited by 179
3,4-Methylenedioxy analogues of amphetamine: Defining the risks to humans
Hegadoren, K. M., Baker, G. B., & Bourin, M. (1999) · Neuroscience & Biobehavioral Reviews · doi:10.1016/s0149-7634(98)00046-3 · Cited by 178
Krystal, J. H., Price, L. H., Opsahl, C., Ricaurte, G. A., & Heninger, G. R. (1992) · The American Journal of Drug and Alcohol Abuse · doi:10.3109/00952999209026070 · Cited by 168
Seiden, L. S., US Department of Health and Human Services; National Institute on Drug Abuse, & Sabol, K. E. (1996) · PsycEXTRA Dataset · doi:10.1037/e495672006-014 · Cited by 166
Neurotransmitters and memory: Role of cholinergic, serotonergic, and noradrenergic systems.
Wenk, G. L., Hughey, D. J., Boundy, V. A., Kim, A., al, E., & Olton, D. S. (1987) · Behavioral Neuroscience · doi:10.1037//0735-7044.101.3.325 · Cited by 156
Serotonergic function after (±)3,4-methylene-dioxymethamphetarnine (‘Ecstasy’) in humans
Gerra, G., Zaimovic, A., Giucastro, G., Maestri, D., Monica, C., Sartori, R., Caccavari, R., & Delsignore, R. (1998) · International Clinical Psychopharmacology · doi:10.1097/00004850-199801000-00001 · Cited by 145
Ramsay, M., & Spiller, J. (1997) · PsycEXTRA Dataset · doi:10.1037/e451752008-001 · Cited by 144
Scheffel, U., Szabó, Z. R., Mathews, W. B., Finley, P. A., Dannals, R. F., Ravert, H. T., Szabo, K., Yuan, J., & Ricaurte, G. A. (1998) · Synapse · doi:10.1002/(sici)1098-2396(199806)29:2<183::aid-syn9>3.0.co;2-3 · Cited by 143
Gerra, G., Zaimovic, A., Ferri, M., Zambelli, U., Timpano, M., Neri, E., Marzocchi, G. F., Delsignore, R., & Brambilla, F. (2000) · Biological Psychiatry · doi:10.1016/s0006-3223(99)00180-8 · Cited by 136
McCann, U. D., Ricaurte, G. A., & Ciraulo, D. A. (1991) · Journal of Clinical Psychopharmacology · doi:10.1097/00004714-199110000-00005 · Cited by 134
Ecstasy (MDMA) in Recreational Users: Self-Reported Psychological and Physiological Effects
DAVISON, D., & Parrott, A. C. (1997) · Human Psychopharmacology Clinical and Experimental · doi:10.1002/(sici)1099-1077(199705/06)12:3<221::aid-hup854>3.0.co;2-c · Cited by 134
Places and patterns of drug use in the Scottish dance scene
FORSYTH, A. J. M. (1996) · Addiction · doi:10.1046/j.1360-0443.1996.9145116.x · Cited by 133
Colado, M. I., Murray, T. K., & Green, A. R. (1993) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.1993.tb12846.x · Cited by 132
Chronic paranoid psychosis after misuse of MDMA ("ecstasy")
McGuire, P. K., & Fahy, T. A. (1991) · BMJ · doi:10.1136/bmj.302.6778.697 · Cited by 130
Subjective reports on the effects of the MDMA (‘ecstasy’) experience in humans
Cohen, R. S. (1995) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/0278-5846(95)00231-6 · Cited by 129
Phenomenology and Sequelae of 3,4-Methylenedioxymethamphetamine Use
Liester, M. B., Grob, C. S., BRAVO, G. L., & WALSH, R. N. (1992) · The Journal of Nervous and Mental Disease · doi:10.1097/00005053-199206000-00001 · Cited by 128
Smith, S. E., Pihl, R. O., Young, S. N., & Ervin, F. R. (1987) · Psychopharmacology · doi:10.1007/bf00216010 · Cited by 120
Chang, L., Grob, C. S., Ernst, T., Itti, L., Mishkin, F. S., Melchor, R., & Poland, R. E. (2000) · Psychiatry Research Neuroimaging · doi:10.1016/s0925-4927(99)00048-7 · Cited by 119
‘Ecstasy’ Psychosis and Flashbacks
Creighton, F. J., Black, D. L., & Hyde, C. E. (1991) · The British Journal of Psychiatry · doi:10.1192/bjp.159.5.713 · Cited by 115
Persistent Effects of (±)3,4-Methylenedioxymethamphetamine (MDMA, “Ecstasy”) on Human Sleep
Allen, R. P., McCann, U. D., & Ricaurte, G. A. (1993) · SLEEP · doi:10.1093/sleep/16.6.560 · Cited by 113
Linnoila, M., Virkkunen, M., George, T., & Higley, D. (1993) · International Clinical Psychopharmacology · doi:10.1097/00004850-199309001-00008 · Cited by 110
Chang, L., Ernst, T., Grob, C. S., & Poland, R. E. (1999) · Journal of Magnetic Resonance Imaging · doi:10.1002/(sici)1522-2586(199910)10:4<521::aid-jmri4>3.0.co;2-9 · Cited by 109
Sabol, K. E., Lew, R., Richards, J. B., Vosmer, G. L., & Seiden, L. S. (1996) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(25)12371-9 · Cited by 106
Ricaurte, G. A., Finnegan, K. T., Irwin, I., & Langston, J. W. (1990) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.1990.tb16919.x · Cited by 102
McCann, U. D. (1997) · JAMA · doi:10.1001/jama.278.8.666 · Cited by 102
Behavioural analysis of the acute and chronic effects of MDMA treatment in the rat
Marston, H. M., Reid, M., Lawrence, J. A., Olverman, H. J., & Butcher, S. P. (1999) · Psychopharmacology · doi:10.1007/s002130050978 · Cited by 101
Tuchtenhagen, F. (2000) · Neuropsychopharmacology · doi:10.1016/s0893-133x(99)00140-2 · Cited by 97
Patterns of ecstasy use by drug users
Hammersley, R. (1999) · The British Journal of Criminology · doi:10.1093/bjc/39.4.625 · Cited by 95
Dafters, R. I., Duffy, F., O'Donnell, P. J., & Bouquet, C. (1999) · Psychopharmacology · doi:10.1007/s002130051035 · Cited by 95
Role of 5-HT in Defensive Behavior and Anxiety
Graeff, F. G. (1993) · Reviews in the Neurosciences · doi:10.1515/revneuro.1993.4.2.181 · Cited by 95
Price, L. H., Ricaurte, G. A., Krystal, J. H., & Heninger, G. R. (1989) · Archives of General Psychiatry · doi:10.1001/archpsyc.1989.01810010022003 · Cited by 93
Lew, R., Sabol, K. E., Chou, C., Vosmer, G. L., Richards, J. B., & Seiden, L. S. (1996) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(25)12372-0 · Cited by 93
Long term psychiatric and cognitive effects of MDMA use
McGuire, P. K. (2000) · Toxicology Letters · doi:10.1016/s0378-4274(99)00219-2 · Cited by 90
McCann, U., Mertl, M., Murphy, D. L., Eligulashvili, V., & Ricaurte, G. A. (1999) · Psychopharmacology · doi:10.1007/s002130051142 · Cited by 85
Mood state and brain electric activity in Ecstasy users
Gamma, A., Frei, E., Lehmann, D., Pascual-Marqui, R. D., Hell, D., & Vollenweider, F. X. (2000) · Neuroreport · doi:10.1097/00001756-200001170-00031 · Cited by 81
Obrocki, J., Buchert, R., Vaeterlein, O., Thomasius, R., Beyer, W., & Schiemann, T. (1999) · The British Journal of Psychiatry · doi:10.1192/bjp.175.2.186 · Cited by 81
Chronic atypical psychosis associated with MDMA ("ecstasy") abuse
Schifano, F. (1991) · The Lancet · doi:10.1016/0140-6736(91)92633-d · Cited by 79
MDMA (Ecstasy) precipitation of panic disorder
Pallanti, S., & Mazzi, D. (1992) · Biological Psychiatry · doi:10.1016/0006-3223(92)90145-p · Cited by 79
Psychiatric illness associated with "ecstasy"
Benazzi, F., & Mazzoli, M. (1991) · The Lancet · doi:10.1016/0140-6736(91)92332-v · Cited by 64
MDMA (“ecstasy”) abuse: Psychopathological features and craving for chocolate: A case series
Schifano, F., & Magni, G. (1994) · Biological Psychiatry · doi:10.1016/0006-3223(94)90088-4 · Cited by 58
Iravani, M. M., Asari, D., Patel, J. C., Wieczorek, W. J., & Kruk, Z. L. (2000) · Synapse · doi:10.1002/(sici)1098-2396(20000615)36:4<275::aid-syn4>3.0.co;2-# · Cited by 56
Aguirre, N., Frechilla, D., García‐Osta, A., Lasheras, B., & Rı́o, J. D. (1997) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.1997.68031099.x · Cited by 55
Frederick, D., Ali, S. F., Slikker, W., Gillam, M. P., Allen, R. R., & Paule, M. G. (1995) · Neurotoxicology and Teratology · doi:10.1016/0892-0362(95)00013-h · Cited by 50
Psychiatric complications of 'Ecstasy' use
Series, H. G., Boeles, S., Dorkins, E., & Peveler, R. (1994) · Journal of Psychopharmacology · doi:10.1177/026988119400800110 · Cited by 43
Kleven, M. S., Woolverton, W. L., & Seiden, L. S. (1989) · Brain Research · doi:10.1016/0006-8993(89)90700-2 · Cited by 38
Toxic effect of MDMA on brain serotonin neurons
Klugman, A., Hardy, S., Baldeweg, T., & Gruzelier, J. H. (1999) · The Lancet · doi:10.1016/s0140-6736(05)66942-5 · Cited by 37
Cohen, R. S. (1996) · Biological Psychiatry · doi:10.1016/0006-3223(95)00551-x · Cited by 35
Modification of 8-OH-DPAT effects on learning by manipulation of the assay conditions
Meneses, A., & Hong, E. (1994) · Behavioral and Neural Biology · doi:10.1016/s0163-1047(05)80041-x · Cited by 32
Seiden, L. S., Woolverton, W. L., Lorens, S. A., Williams, J. E. G., Corwin, R. L., Hata, N., & Olimski, M. (1993) · PsycEXTRA Dataset · doi:10.1037/e495922006-004 · Cited by 27
Garvey, M. J., Noyes, R., WOODMAN, C. L., & Laukes, C. (1995) · Psychiatry Research · doi:10.1016/0165-1781(94)02510-p · Cited by 23
McGuire, P. K., & Fahy, T. (1992) · The British Journal of Psychiatry · doi:10.1192/bjp.160.2.276a · Cited by 21
Panic Disorder Induced by Large Doses of 3,4-Methylenedioxymethamphetamine Resolved by Paroxetine
Windhaber, J., Maierhofer, D., & Dantendorfer, K. (1998) · Journal of Clinical Psychopharmacology · doi:10.1097/00004714-199802000-00021 · Cited by 21
Psychiatric sequelae of MDMA (ecstasy) and related drugs
Cassidy, G., & Ballard, C. G. (1994) · Irish Journal of Psychological Medicine · doi:10.1017/s0790966700014841 · Cited by 16
Cited by
The Pharmacology and Clinical Pharmacology of 3,4-Methylenedioxymethamphetamine (MDMA, “Ecstasy”)
Green, A. R., Mechan, A. O., Elliott, J. M., O’Shea, E., & Colado, M. I. (2003) · Pharmacological Reviews · doi:10.1124/pr.55.3.3 · Cited by 1,272
DEPARTMENT OF HEALTH & HUMAN SERVICES
Schuchat, A. (2015) · Pharmacy Today · doi:10.1016/s1042-0991(15)32122-8 · Cited by 1,098
Human Pharmacology of MDMA: Pharmacokinetics, Metabolism, and Disposition
de la Torre, R., Farré, M., Roset, P. N., Pizarro, N., Abanades, S., Segura, M., Segura, J., & Camí, J. (2004) · Therapeutic Drug Monitoring · doi:10.1097/00007691-200404000-00009 · Cited by 444
Human psychopharmacology of Ecstasy (MDMA): a review of 15 years of empirical research
Parrott, A. C. (2001) · Human Psychopharmacology: Clinical and Experimental · doi:10.1002/hup.351 · Cited by 344
Recreational Ecstasy/MDMA, the serotonin syndrome, and serotonergic neurotoxicity
Parrott, A. C. (2002) · Pharmacology Biochemistry and Behavior · doi:10.1016/s0091-3057(01)00711-0 · Cited by 324
Metadata
- Authors
- Morgan, M. J.
- Venue
- Psychopharmacology
- Published
- 2000-09-07
- Volume
- 152
- Issue
- 3
- Pages
- 230-248
- ISSN
- 0033-3158 (ISSN-L)
- 1432-2072
- OpenAlex
- W2164537538
- Cited by
- 380
- References
- 115
- FWCI
- 27.36
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.